 |
Free
Access to abstracts at PubMed
PUBLICATIONS
- North RB, Han M, Zahurak M, Kidd DH: Radiofrequency lumbar
facet denervation: analysis of prognostic factors. Pain 1994 Apr;57(1):77-83
- Han M, Burnett AL, Fishman EK, Marshall FF: The natural history
and treatment of adrenal myelolipoma. J Urol. 1997 Apr;157(4):1213-6
- Han M, Schoenberg MP: The use of molecular diagnostics in
bladder cancer. Urologic Oncology 2000; 5(3):87-92.
- Han M, Nelson JB: Non-steroidal anti-androgens on prostate
cancer-current treatment practice. Exp Opin Pharmacother 2000;
1(3):443-449.
- Han M, Partin AW, Walsh PC, Rodriguez R: Ability of the 1992
and 1997 American Joint Committee on Cancer (AJCC) staging systems
for prostate cancer to predict progression free survival following
radical prostatectomy for T2 disease. J Urol. 2000; 164 (1): 89-92.
- Han M, Snow PB, Brandt JM, Partin AW: Evaluation of artificial
neural networks for the prediction of pathological stage in prostate
cancer, Cancer 2001; 91(S8):1661-6.
- Han M, Pound CR, Potter SR, Partin AW, Epstein JI, Walsh PC:
Isolated local recurrence is rare following radical prostatectomy
for men with Gleason 7 diseases and positive surgical margins:
Therapeutic implications, J Urol. 2001;165(3):864-6.
- Batuello JT, Gamito EJ, Crawford ED, Han M, Partin AW, McLeod
DG and O’Connell C: An artificial neural network model for
the assessment of lymph node spread in patients with clinically
localized prostate cancer, Urology 2001; 57(3):481-5.
- Han M, Snow PB, Epstein JI, Chan TY, Jones KA, Walsh PC and
Partin AW: A neural network predicts progression for men with
Gleason score 3+4 versus 4+3 tumors following radical prostatectomy,
Urology 2000; 56(6):994-9.
- Han M, Kronz JD, Schoenberg MP: Testicular metastasis of
the transitional cell carcinoma of the prostate. J Urol. 2000;
164 (12): 2026.
- Han M, Potter SR, Partin AW: The role of free Prostate-Specific
Antigen in prostate cancer detection, Current Urology Reports
2000; 1:78-82.
- Han M, Piantadosi S, Zahurak ML, Sokoll LJ, Chan DW, Epstein
JI, Walsh PC and Partin AW: Serum acid phosphatase level and biochemical
recurrence following radical prostatectomy for men with clinically
localized prostate cancer. Urology 2001 Apr;57(4):707-11.
- Han M, Partin AW, Epstein JI, Walsh PC: Era-specific biochemical
recurrence-free survival following radical prostatectomy for clinically
localized prostate cancer, J Urol. 2001 Aug;166(2):416-9.
- Han M, Partin AW: The role of ProstaScint scan (111In-capromab
pendetide scan), Reviews in Urology 2001; 3 (4):165-71.
- Barocas DA, Han M, Epstein JI, Chan DY, Trock BJ, Walsh PC,
and Partin AW: Does capsular incision at radical retropubic prostatectomy
affect disease-free survival in otherwise organ-confined prostate
cancer, Urology 2001 Nov;58(5):746-51.
- Roberts WW, Bergstralh EJ, Blute ML, Slezak JM, Carducci
M, Han M, Epstein JI, Eisenberger MA, Walsh PC and Partin AW:
Contemporary identification of patients at high risk of early
prostate cancer recurrence after radical retropubic prostatctomy.
Urology 2001 Jun;57(6):1033-7.
- Han M, Partin AW: Nomograms for Clinically Localized Prostate
Cancer. Part I. Radical Prostatectomy, Seminars in Urologic Oncology
2002 May; 20 (2): 123-30.
- Gretzer MB, Trock BJ, Han M, Walsh PC: A critical analysis
of the interpretation of biochemical failure in surgically treated
patients using the American Society for Therapeutic Radiation
and Oncology criteria, J Urol 2002 Oct;168(4 pt 1): 1419-22.
- Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh
PC: Prediction of biochemical (PSA) recurrence following radical
prostatectomy for clinically localized prostate cancer. J Urol
2003 Feb; 169 (2):517-23.
- Han M, Partin AW, Chan DY, Walsh PC: An evaluation of the
decreasing incidence of positive surgical margins in a large retropubic
prostatectomy series. J Urol 2004 Jan; 171 (1):23-6.
- Han M, Nadler RB, Catalona WJ: Point and Counterpoint Debate
on the Approaches to Radical Prostatectomy, In Favor of the Traditional
Radical Retropubic Prostatectomy (RRP). Contemporary Urology 2004
Feb; 16(2): 38-45.
- KHan MA, Han M, Partin AW, Epstein JI, Walsh PC: Long-term
cancer control of radical prostatectomy in men younger than 50
years of age: update. Urology 2003 Jul; 62(1): 86-91.
- Antenor AV, Han M, Roehl KA, Nadler RB, Catalona WJ: Relation
between initial screening PSA level and subsequent prostate cancer
detection in a longitudinal screening population. J Urol 2004
Jul; 172(2): 90-93.
- Roehl KA, Han M, Ramos CG, Antenor JV, Catalona WJ: Cancer
Progression and Survival Rates After Anatomic Radical Retropubic
Prostatectomy in 3,478 Consecutive Patients: Long-Term Results.
J Urol 2004 Sep; 172 (4): 910-4.
- Eggener SE, Roehl KA, Smith ND, Antenor JV, Han M, Catalona
WJ: Contemporary Survival Results and the Role of Radiation Therapy
in Patients with Seminal Vesicle Invasion Following Radical Prostatectomy.
J Urol 2005 Apr; 173 (4): 1150-5.
- Antenor JV, Roehl KA, Eggener SE, Kundu SD, Han M, Catalona
WJ: Preoperative PSA and Progression-Free Survival Following Radical
Prostatectomy for Stage T1c disease. Urology. 2005 Jul;66(1):156-60.
- Kundu SD, Roehl KA, Eggener SE, Antenor JV, Han M, Catalona
WJ: Potency, Continence and Complications in 3,477 Consecutive
Radical Retropubic Prostatectomies. J Urol 2004 Dec; 172 (6):2227-31.
- Jang TL, Han M, Catalona WJ: More Favorable Tumor Features
and Progression-Free Survival Rates in a Longitudinal Prostate
Cancer Screening Study: PSA Era- and Threshold-Specific Effects.
Urology (submitted)
- Han M, Brannigan RE, Antenor JV, Roehl KA, Catalona WJ: The
Association between Hemospermia and Prostate Cancer. J Urol 2004
Dec; 172 (6):2189-92.
- Loeb S, Han M, Roehl DA, Antenor JV, Catalona WJ: Accuracy
of Prostate Size Estimation by Digital Rectal Examination Versus
Transrectal Ultrasonography. J Urol 2005 Jan;173(1):63-5.
- Kundu SD, Grubb RL, Roehl KA, Antenor JV, Han M, Catalona
WJ: Delays in Cancer Detection Using Two- and Four-Year Screening
Intervals for Prostate Cancer Screening with Initial PSA Less
than 2 ng/mL. J Urol 2005 Apr; 173 (4):1116-20.
- Gonzalez C, Roehl KA, Antenor JV, Blunt LW, Han M, Catalona
WJ: Preoperative PSA Level Significantly Associated with Interval
to Biochemical Progression After Radical Retropubic Prostatectomy.
Urology 2004 Oct, 64 (4):723-8.
- Kundu SD, Han M, Catalona WJ: Should an Isolated Humeral
Lesion Detected During Prostate Cancer Metastatic Survey be Biopsied?
J Urol 2004 Nov;172(5 Pt 1):1825-6.
- Loeb S, Gonzalez CM, Han M, Roehl KA, Antenor JAV, Yap R,
and Catalona WJ: Does Prostate-Specific Antigen (PSA)- Based Screening
Detect Harmless Prostate Cancer?
- Han M, Partin AW: Authors’ Reply Letter to the article
“An evaluation of the decreasing incidence of positive surgical
margins in a large retropubic prostatectomy series.” J Urol.
2005 May;173(5):1828.
- Pazona J, Han M, Hawkins SA, Catalona WJ: Salvage Radiation
Therapy for PSA Progression Following Radical Prostatectomy: 10-year
Outcome Estimates. J Urol. 2005 Oct;174(4 Pt 1):1282-6.
- Gann PH, Han M: The Natural History of Clinically Localized
Prostate cancer. Editorial. JAMA 2005 May; 293(17): 2149-2151.
- Han M, Smith ND, Antenor JAV, Roehl KA, Catalona WJ: Does
Transurethral Resection of the Prostate (TURP) Compromise the
Subsequent Radical Retropubic Prostatectomy (RRP) Outcomes?. Urology
(submitted).
- Dale W, Bilir P, Han M, Meltzer D: The role of Anxiety in
Prostate Carcinoma. Cancer 2005 June 15.
- Han M, Yu X, Gashti SN, Yeh JT, Hawkins SA, Pattison MR,
Catalona WJ: Histopathologic Features of Prostate Tumors Detected
at Different PSA Levels in the Contemporary PSA Era. (in preparation)
- Han M, Pattison MR, Hawkins SA, Yu X, Liao L, Catalona WJ:
Prediction of Advance Prostate Cancer Using Biopsy Parameters:
The contribution of Tumor Percentage, Volume, and the Number of
Positive Biopsy Cores. (in preparation)
- Macejko A, Han M, Kozlowski J, Hawkins SA, Antenor JAV, Roehl
KA, Yu X, Catalona WJ: Do Most Patients with a PSA-detected Prostate
Cancer and a Very Large Prostate Gland have a “Clinically
Insignificant” Tumor. (in preparation)
BOOK CHAPTERS
- Han M, Polascik TJ: Chapter 5. Urologic procedures. Johns Hopkins
Manual of Common Bedside Surgical Procedures. Chen H, Sonnandy C,
Lillemoe K. Williams & Wilkins. 1999.
- Han M, Schoenberg MP: In vitro testing of bladder tumor. American
Urological Association Update Series 2001 Vol XX, Lesson 28, 218-23.
- Han M, Partin AW: Chapter IV. Anatomic radical retropubic
prostatectomy for prostate cancer. Prostate cancer in the 21st
century. Chung L, Isaacs J, Simons J. The Humana Press, Inc. 2001,
377-386.
- Han M, Partin AW: The role of free PSA (prostate-specific
antigen) and hK-2 (human kallikrein-2) in prostate cancer detection.
American Urological Association Update Series 2001.
- Han M, Alfert H, Partin AW: Chapter 41, Retropubic and suprapubic
open prostatectomy. Campbell’s Urology, 8th edition, Walsh,
Retik, Vaughan and Wein. Saunders.
- Han M, Partin AW, Pound CR, Epstein JI, Walsh PC: Long-term
biochemical disease-free and cancer-specific survival following
anatomic radical retropubic prostatectomy: The 15-year Johns Hopkins
experience. Urologic Clinics of North America 2001 Aug; 29 (3):555-65.
- Han M, Catalona WJ: Anatomic Nerve-Sparing Radical Retropubic
Prostatectomy. Urologic Oncology 2004, Chapter 29: 514-27.
- Han M, Gann PH, Catalona WJ: PSA and Screening for Prostate
Cancer. Medical Clinics of North America 2004 Mar; 88(2):245-65.
- Han M, Catalona WJ: What Is the Best PSA Prompt for Biopsy?
AUA News March 2004; 9(2):30-1.
- Han M, Catalona WJ: New Markers for Prostate Cancer. Urologia
Contemporânea (in press).
- Han M, Catalona WJ: New Markers for Prostate Cancer: Renal
and Urology News July/August 2004, 39-40.
- Han M, Partin AW: Multivariate Models for Predicting Pathological
Stage. Prostate Cancer: Principles and Practice, Kirby, Fenley,
Parsons, Partin (in press).
- Han M, Catalona WJ: New Concepts in Early Detection of Prostate
Cancer. Prostate Cancer: Principles and Practice, Kirby, Fenley,
Parsons, Partin (in press).
- Han M, Partin AW: Chapter , Retropubic and suprapubic open
prostatectomy. Walsh Campbell’s Urology, 9th edition, Wein,
Peters, Kavoussi, Partin and Someone. Saunders.
- Han M, Catalona WJ: Management of Prostate Cancer. Walsh
Campbell’s Urology, 9th edition, Wein, Peters, Kavoussi,
Partin and Someone. Saunders.
VIDEOS
- Han M, Chan DY, Jackman SV, Fabrizio MF, Kavoussi LR, Jarrett
TW: The "Mini-Perc" technique: a less invasive alternative
to standard percutaneous nephrolithotomy. Presented at the 94th
AUA Annual Meeting, V47, Dallas, TX, May 1999. AUA Video Library
HV 2209.
ABSTRACTS
- Han M, Snow PB, Chan TY, Epstein JI, Walsh PC, Partin AW: Ability
of an artificial neural network to predict progression-free survival
for men with Gleason score 3+4 versus Gleason score 4+3 tumors following
radical prostatectomy. AUA 2000, Atlanta, GA
- Han M, Partin AW, Walsh PC, Rodriguez R: Ability of the 1992
and 1997 American Joint Committee on Cancer (AJCC) staging systems
for prostate cancer to predict progression free survival following
radical prostatectomy for T2 disease. AUA 2000, Atlanta, GA
- Walsh PC, Han M, Pound CR, Epstein JI, Partin AW: Isolated
local recurrence is rare following radical prostatectomy for men
with Gleason 7 disease who have positive surgical margins: therapeutic
implications. AUA 2000, Atlanta, GA
- Han M, McCadden J, Rodriguez R: Estrogenic effect of Glucosamine
Sulfate/Chondroitin Sulfate. Mid-Atlantic Section AUA 2000, Rio
Grande, PR
- Han M, Lai S, Partin AW, Epstein JI, Walsh PC: Prediction
of biochemical (PSA) recurrence following radical prostatectomy
for clinically localized prostate cancer. AUA 2001, Annaheim,
CA, Mid-Atlantic Section AUA 2000, Rio Grande, PR
- Nielson ME, Han M, Walsh PC, Partin AW: Pathologic outcome
and biochemical recurrence in African-American and Caucasian men
following radical prostatectomy for clinically localized prostate
cancer: Mid-Atlantic Section AUA 2002, Baltimore, MD, AUA 2003,
Chicago, IL
- Han M, Chan DYC, Partin AW: An evaluation of the decreasing
incidence of positive surgical margins in a large radical retropubic
prostatectomy series. AUA 2003, Chicago, IL
- Han M, Hawkins SA, Catalona WJ: Salvage Radiation Therapy
for PSA Progression Following Radical Prostatectomy: 10-year Outcome
Estimates. AUA 2004, San Francisco, CA
- Han M, Brannigan RE, Catalona WJ: The Association Between
Hematospermia and Prostate Cancer. AUA 2004, San Francisco, CA
- Han M, Hawkins SA, Catalona WJ: Two Distinct Types of Prostate
Cancer Are Detected With Digital Rectal Examination at PSA Levels
Below 2.6 ng/mL. AUA 2004, San Francisco, CA
- Jang TL, Han M, Catalona WJ: More Favorable Tumor Features
and Progression-Free Survival Rates in a Longitudinal Prostate
Cancer Screening Study: PSA Era- and Threshold-Specific Effects.
AUA 2004, San Francisco, CA
- Lee SH, Deaton RJ, Han M, Chow YC, Gann PH: Free PSA and
Prediction of Prostate Cancer Among Men Undergoing Repeat Prostate
Biopsies. AUA 2004, San Francisco, CA
- Han M, Smith ND, Catalona WJ: Does Transurethral Resection
of Prostate Compromise the Subsequent Radical Retropubic Prostatectomy
Outcomes? AUA 2004, San Francisco, CA
- Rubenstein J, Han M, Hawkins SA, Catalona WJ: Adjuvant Radiation
Therapy Following Radical Retropubic Prostatectomy for Adverse
Pathology. AUA 2004, San Francisco, CA
- Williams D, Land S, Han M, Brannigan R: Paternity Rates in
the US 1993-2002: Analysis of Birth Rates by Paternal Age and
Race. American Society for Reproductive Medicine 2004, Philadelphia,
PA
- Yang XJ, Han M, Catalona WJ: MHL-1: New Immunohistochemical
Marker for Prostate Cancer. AUA 2005, San Antonio, TX
- Yu X, Han M, Gashti SN, Yeh JT, Roehl KA, Catalona WJ: Comparison
of Different Methods for Calculating PSA Velocity: Importance
of Time Interval Prior to Diagnosis of Prostate Cancer. AUA 2005,
San Antonio, TX
- Gashti SN, Roehl KA, Yu X, Antenor JAV, Yeh JT, Han M, Catalona
WJ: Perineural Invasion: Surrogate Marker for the Extent of Cancer
in Radical Prostatectomy Specimens. AUA 2005, San Antonio, TX
- Macejko A, Han M, Kozlowski J, Hawkins SA, Antenor JAV, Roehl
KA, Yu X, Catalona WJ: Do Most Patients with a PSA-detected Prostate
Cancer and a Very Large Prostate Gland have a “Clinically
Insignificant” Tumor: AUA 2005, San Antonio, TX
- Antenor JAV, Roehl KA, Han M, Catalona WJ: PSA Velocity Cutoff
for Recommending Biopsy: Positive Predictive Value. AUA 2005,
San Antonio, TX
- Neilsen ME, Han M, Walsh PC, Partin AW, Freedland SJ: Body
Mass Index and Outcomes in African-American and Caucasian Men
Following Radical Prostatectomy for Clinically Localized Prostate
Cancer. AUA 2005, San Antonio, TX
- Han M, Pattison MR, Hawkins SA, Yu X, Bedford DF, Liao L,
Catalona WJ: Prediction of Advance Prostate Cancer Using Biopsy
Parameters: The contribution of Tumor Percentage, Volume, and
the Number of Positive Biopsy Cores. AUA 2005, San Antonio, TX
- Catalona, WJ, Yu X, Roehl KA, Yeh JT, Gashti SN, Antenor
JAV, Han M: Serum PSA correlates more strongly with Percentage
of Cancer and Cancer Volume than with Prostate Size. AUA 2005,
San Antonio, TX
- Loeb S, Yu X, Roehl KA, Antenor JAV, Yeh JT, Gashti SN, Han M, Catalona WJ: Predicting Adverse Pathology and Cancer Progression:
Comparison of Tumor Volume, Perineural Invasion, Percent Cancer
and Lymphovascular Invasion in Radical Prostatectomy Specimen.
AUA 2005, San Antonio, TX
- Eggener SE, Roehl KA, Han M, Catalona WJ: Predictors of Subsequent
Prostate Cancer in Men with a PSA Level of 2.6-4.0 ng/mL and An
Initially Negative Biopsy. AUA 2005, San Antonio, TX
- Han M, Yu X, Gashti SN, Yeh JT, Hawkins SA, Pattison MR,
Bedford DF, Catalona WJ: Histopathologic Features of Prostate
Tumors Detected at Different PSA Levels in the Contemporary PSA
Era. AUA 2005, San Antonio, TX.
|
|
|
|
